Wellington Management Group’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Wellington Management Group's PALI Position: Q3 2026 in Review
Wellington Management Group increased its Palisade Bio (PALI) stake by 46% in Q3 2026, buying an estimated $3.33M and bringing the position to 5,410,568 shares worth $7.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1364.
Wellington Management Group first reported a position in PALI in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.74M in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Wellington Management Group held 5,410,568 shares of Palisade Bio worth $7.3M as of Q3 2026.
- Wellington Management Group bought 1,706,632 Palisade Bio shares in Q3 2026, an estimated $3.33M.
- Palisade Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1364 holding.
- Wellington Management Group first reported a position in Palisade Bio in Q1 2026 and has held it in 3 quarters since.
- Wellington Management Group's Palisade Bio position peaked at $7.74M in Q2 2026.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.